Our current finding of DANCR’s decline in inflammation-prone lung tissue, in tandem with the accumulating evidence pertaining to DANCR’s role in inflammation and in infected cell cultures, led to our prediction that DANCR’s decline might play a role in COVID-19. Here, DANCR is linked to COVID-19.